Research at MSK Our research impact Research topics Core facilities & resources ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...
Saad Usmani, MD, Chief of MSK’s Myeloma Service, says the new combination therapy could be a “big step forward for people with extramedullary myeloma.” Researchers have made great progress in the ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Gently step forward until you feel a gentle stretch across your chest and in front of your shoulders. Keep your back straight and your neck and shoulders relaxed. Hold for 30 seconds, then relax.
If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Tanto en las leucemias agudas como en las crónicas, a medida que aumenta el número de células leucémicas, las células normales se desplazan fuera de la médula ósea y los síntomas pueden comenzar a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback